Post mortem and in vivo dissolution rates of freshly induced venous thromboemboli were determined in 87 dogs. In 63, fresh thrombi formed in the inferior vena cava (IVC) were embolized to the lungs. Dissolution rates were determined by comparing the embolic volume recovered at autopsy with the volume of a second (control) thrombus formed in the IVC. Embolic volume recovered at 3 hr post mortem averaged 50.2% of control. In dogs maintained alive, embolic volume fell to 48.4% of control at 3 hr. With concomitant heparinization, only 34% of control embolic volume remained at 3 hr. In 24 dogs, thrombi were formed in the jugular veins.
Venous thrombi fibrinolysis
Fibrinolysis man.6-14 However, these reports have been based on postmortem examination, pulmonary angiography, or pulmonary scintiphotography-methods which do not permit precise quantification of the extent of embolic resolution.
In the studies reported here, we have attempted to quantify the rates at which fresh pulmonary emboli and venous thrombi resolve in the dog.
Dissolution rates were determined under several conditions: in the post mortem period, in the living dog without therapy, and in the living dog with concomitant heparin therapy.
Methods
Eighty-seven mongrel dogs weighing between 16 and 20 kg were studied. In 63, resolution rates of pulmonary emboli were determined; in 24 , resolution rates of peripheral venous (jugular) thre abi were determined.
Pulmonary Emboli
All dogs were anesthetized with sodium pentobarbital (30 mgm/kg body wt i.v.) and placed on the left side. The inferior vena cava (IVC) was approached retroperitoneally and freed between the renal veins and Circulation, Volume XLVIII, July 1973 its bifurcation by ligating and sectioning each collateral. Two ligatures or atraumatic clamps were then placed at the ends of the isolated IVC segment.
A 5-7 cm long clot was formed in the IVC using the technique described by Wessler. 15 16 Thirty ml of heterologous, thrombin-free, human serum eluate were injected into one of the jugular veins over a period of 10-15 sec. When serum eluate was not available, 60 ml of defibrinated human plasma were injected instead.* Within 60 sec after completion of this injection, blood in the isolated IVC segment was trapped between the two ligatures or clamps. In each instance, rapid formation of a firm clot could be verified by external palpation of the IVC. Thirty minutes after thrombus formation, the ligatures were released and embolism achieved, venous return to the heart being accelerated by massage of the lower extremities. Within 3 min after this first clot was released, a second clot was formed in the IVC by identical technique. At this point, the dogs were divided into four groups.
Group I (Control Group) Ten dogs were sacrificed immediately after formation of the second IVC clot. Careful autopsy of the right ventricle and pulmonary arteries was performed. The embolic thrombus was recovered from the cardiopulmonary vasculature and its volume measured by displacement of water in a graduated glass cylinder. The control thrombus remained undisturbed in the IVC of the dead dog for 30 min, then was removed and its volume measured. The volume of the control thrombus in the IVC included clot originating from the veins distal to the clamped segment following vigorous leg massage. Thus, the volume of clot recovered from the lungs-which was 33 min old-was compared with that of the IVC clot-which was 30 min old. Group 
II
In 18 dogs, the IVC clot volume was again determined 30 min after death, but recovery of the emboli from the right cardiac chambers and pulmonary arteries was delayed until 3, 6, or 12 hr after death in six dogs each. Group 
III
In 19 dogs the IVC thrombus was again recovered and measured 30 min after formation. Eleven dogs were sacrificed 3 hr after release of the initial clot; 8, at 6 hr following embolization and emboli recovered from the right cardiac chambers and pulmonary arteries. Group IV In 16 dogs, heparin was administered (4000 USP units i.v.), 30 min after formation of the control IVC thrombus. Three hours later, the animal was sacrificed and the volume of control (IVC) thrombus and pulmonary emboli determined.
In each dog, the search for embolic material involved careful dissection of the right atrium, right ventricle, and the pulmonary arterial tree down to vessels 1 mm in diameter. In addition, at least three biopsies from each lung (upper, middle, and lower zones) were taken and examined microscopically for evidence of emboli within smaller arterial vessels. No microscopic emboli were found in any instance.
No difficulty was encountered in distinguishing antemortem from post mortem thrombotic material in the right cardiac chambers and pulmonary vasculature because of special precautions observed. In our experience, and in that of others,'7 animals sacrificed after prolonged stress or after intravenous injection of KC1 demonstrate substantial post mortem clot within the right cardiac chambers and pulmonary vasculature. However, in preliminary studies we found that such post mortem clots did not occur when dogs were sacrificed instantly by injecting a KC1 bolus directly into the right heart via a catheter. This was the procedure used in Groups I and II. Post mortem clotting was prevented in Group III by injecting 4000 units of heparin 2 min before sacrifice. Group IV dogs, as mentioned, received heparin 3 hr before sacrifice.
Group III and IV dogs were hyperinflated for several breaths every 20-30 min to minimize atelectasis and hypoxemia, and sodium bicarbonate was administered to some dogs to maintain constant pH. All dogs were maintained at room temperature (22 +-PC) until completion of the experiment.
Peripheral Venous Thrombi
In 24 dogs, bilateral jugular venous thrombi 6 cm in length were formed by the Wessler technique. Thirty minutes later the right jugular venous thrombus (control clot) was removed in all dogs and its volume measured. At this point the dogs were divided into three groups. Group A In six dogs, the left thrombus was exposed to systemic circulation for 2 min by loosening the ligatures, then the dogs were sacrificed. The exposed thrombus remained undisturbed in the left jugular vein of the dead dog. Six hours after death, the thrombus was recovered and its volume compared to that of the control clot previously recovered from the right side. Group B In six dogs the left thrombus remained isolated between ligatures until the dog was sacrificed 3 hr later.
*To human plasma kept in a refrigerator at 40C were added 2 units of topical thrombin (Parke Davis) per ml of plasma. After thorough mixing the plasma was kept in the refrigerator for an hour to allow complete clotting of the fibrin. Then the serum was separated by filtration, and kept frozen at -200C. It was not used for at least three days and was thawed to room temperature before injection.
Circulation, Volume XLVIII, July 1973 Group C In the other 12 dogs, the left jugular thrombus was exposed to systemic circulation by loosening the ligatures. Six of these animals were sacrificed at 3 hr; the other six, at 6 hr. The volume of the left jugular venous clot was compared to that of the control thrombus in all dogs. In Groups Ill, A, and C, the weight as well as the volume of the clots was determined. In some instances, microscopic examination of the thrombi was carried out.
Results
In all instances red, firm, well-circumscribed venous thrombi were obtained by the method described ( fig. lA ). The amount of control clot formed in all dogs studied averaged 4.0 ml in the IVC and 1.22 ml in the jugular vein (JV). No ffL'erence in control clot volume was found between the dogs in which Wessler serum was used and the dogs which received defibrinated human plasma. Clot distal to the isolated venous segment was often nioted at autopsy and was included in the control volume data. In the embolization studies, most of the emboli were recovered from the main and lobar braniches of the pulmonary vascular tree; more rarely, from the maini pulmonary artery itself or from second and third order arteries. On three occasions, part of the initial embolus was recovered from the right ventricle. G.oup II In this group, studied at specified intervals after death, results obtained in dogs sacrificed immediately were compared with those obtained in dogs evaluated at A=IVC thrombus (control clot), red, firm, well-circumscribed. B= pulmonary thromboemboli after being exposed to circulating blood flow for 3 hr (91%o dissolution by volume). Note the size, branching, and whitish color of the exposed thromboemboli. In vivo dissolution rate of fresh pulmonary thromboemboli (Group III). Pulmonary clot volume recovered from dogs which were kept alive for 3 and 6 hr after embolization is compared with IVC thrombus volume (control clot). Results at 0, 3, and 6 hr are expressed as percents of the IVC control thrombus.
Group IV In this group, which received heparin immediately after embolization and was allowed to survive 3 hr, only 34.0 + 4.9% of control volume was recovered. This result is significantly less (P < 0.05) than the percent recovery at 3 hr post mortem (Group II) or after 3 hr of in vivo exposure in nonheparinized animals (Group III).
Peripheral Venous Thrombi Group A
Post mortem dissolution comparison of JV thrombi disclosed no significant differences between the volume of thrombi removed immediately before death (control clots) and the volume recovered 6 hr after death from the contralateral vein. The volume of this thrombus, which had been exposed to blood post mortem for 6 hr, was 110 + 11.5% of control.
Group B
Comparison of JV thrombi disclosed no signfficant differences between the volume of thrombi removed immediately after formation and the volume recovered 3 hr later from the thrombi isolated in the nonperfused contralateral vein. This volume was 107 + 4.7% of the control.
Group C When the contralateral thrombus was exposed to circulating blood, clot volume recovered at 3 hr Circulation, Volume XLVIII, July 1973 GROUP C TIME (HOURS) Figure 4 In vivo dissolution rate of fresh jugular venous thrombi exposed to circulating blood (Group C). Left jugular thrombus volume recovered from dogs after 3 and 6 hr of jugular vein reperfusion is compared with the contralateral jugular thrombus volume (control clot). Results at 0, 3, and 6 hr are expressed as percents of the contralateral jugular thrombus volume. averaged 67.2 + 5.1% of control volume; and at 6 hr, 57.7 + 6.5% ( fig. 4 ). Differences in clot recovered between zero time (Control JV) and 3 and 6 hr (reperfused JV) were significant (P<0.02 and P <0.005 respectively). Differences at 3 and 6 hr were not significantly different from each other.
Weight vs Volume Decrements
Clots in Groups III, A, and C were also weighed (table 1). In Groups III and C volume decreased somewhat more than weight, so that specific gravity of the clots increased slightly with time. In Group A, in which volume did not change, weight also *The relative decline in volume and weight of pulmonary emboli (Group III) and peripheral venous thrombi (Groups A and C) in various groups is expressed as percentage of the control thrombus volume and weight. Values given are means. None of the volume-weight differences is statistically significant (P > 0.05). 0 i stayed practically the same. However, none of the weight-volume differences achieved statistical significance.
Other Observations
In all except three cases, embolic material recovered from the lungs was fragmented, rather thani appearing as one large IVC cast. All emboli recovered from Group III dogs showed striking morphologic changes, both macroscopically and microscopically, when compared with control IVC thrombus. Not only were these emboli substantially reduced in size, but in contrast to the fresh red control IVC thrombus, the emboli had developed a whitish-grey covering. This coating also was noted in thrombi recovered from the reperfused jugular veins. Such macroscopic differences were not observed in those emboli or JV thrombi not exposed to the circulating blood. Group III emboli were not only "coated" and markedly reduced in size but also often disclosed branching into the smaller pulmonary arteries, in contrast to the smooth, cast-like appearance of control thrombi ( fig. iB) .
Microscopic studies showed that both the control IVC and JV thrombi and those emboli and thrombi not exposed to circulating blood consisted of a central core of red blood cells packed together in a fine meshwork of fibrin, surrounded by a thin, superficial layer of hyaline material (presumably of platelet origin) with some leueocytes and red blood cells scattered through it ( fig. 5 ). Emboli exposed to the circulating blood in the presence of heparin looked similar. Emboli and thrombi which had been exposed to the circulating blood in nonheparinized animals demonstrated a central core of the same composition as the nonexposed clots. However, a thick superficial layer consisting of numerous strands of fibrin and masses of hyaline material Figure 5 Hematoxylin/eosin stain (X 100). A portion of an IVC thrombus (control clot) is shown with its central core (c) of red blood cells and its superficial layer (1) of hyaline material with fewer cells scattered through it. Fibrin is present but evenly mixed with the blood cells and not readily visible. similar to the lines Zahn described in aged human thromboemboli covered this core (fig. 6 ). This thick layer was the microscopic counterpart of the macroscopic whitish-grey coating. These findings are similar to those described by Wessler, et al. '6 The greatest part of the branching described above was formed by this newly-layered material.
Discussion
The Wessler technique has long been recognized as a simple, relatively nontraumatic method for inducing thromboemboli which closely mimic those occurring spontarceously in vivo." 15, 16 The method is highly reliable in terms of production and extent of thrombus induced in a given animal. The results in Group I further verify this reliability. By inducing two IVC thrombi-one released to the lungs, the other retained in situ-each dog served as his own control to provide a reliable estimate of the embolic volume initially released. Further, this double-thrombus technique allowed us to measure clot volume directly without violating vascular integrity prior to autopsy. Such quantification of the amount of residual thrombus is not possible with clinical methods like angiography or scintiphotograp h y 3, is
Data Regarding Resolution Rates
With respect to post mortem embolic resolution, we recovered only 50.2% of the control embolic volume in dogs 3 hr after death. Beyond 3 hr, the reduction in volume was not significantly greater, suggesting that the responsible mechanisms were no longer as active. No comparable post mortem data are available in the literature.
Some prior observations do exist regarding in vivo resolution. Substantial embolic resolution has been described in dogs and rabbits within hours to days after embolization. 1 2,4-7 However, these reports are based on post mortem examinations or angiography 5-7 17 methods which do not permit direct quantification of resolution rate in the manner we have described. Reports dealing with man also have documented resolution of pulmonary emboli over periods of hours to days.8-14 These reports, however, are subject to even greater Figure 6 Phosphotungstic acid/hematoxylin stain (X 100). A portion of a pulmonary thromboembolus exposed to circulating blood for 3 hr. The central core (c) is unchanged. The superficial layer (1) is thicker and reveals numerous strands af fibrin (f) stained by the phosphotungstic acid.
interpretive limitations than those in animals. Extent of embolism was defined by pulmonary angiography or scintiphotography, techniques which do not permit precise quantification. Furthermore, it is not possible to distinguish between fresh and aged emboli in such studies, and aging of emboli prior to release will prolong the time required for resolution.' Concomitant cardiopulmonary disease, present in many of these patients, also appears to delay resolution.7' [12] [13] [14] 19 It is also likely that the application of anticoagulant therapy in these patients conditioned resolution rates, for reasons mentioned below. Despite these interpretive limitations, it is clear that patients with massive embolism can return to angiographic-scan normality, even without anticoagulant therapy, in periods as short as seven days.8 9 Our data indicate that, under ideal circumstances, in vivo resolution proceeds with great dispatch in the dog, and that anticoagulation with heparin accelerates the process. Without heparin, embolic volume declined to 48.4% of initial volume at 3 hr; with heparinization, to 34% of control volume within 3 hr. Jugular thrombi exposed to the circulating blood resolved somewhat more slowly than emboli-to 67% control volume at 3 hr.
Mechanisms Responsible for the Clot Volume Decrements Observed
We regard fibrinolysis as the process responsible for the reduction in thromboembolic volume noted in this study. Alternative explanations might include retraction, organization, and technical failure to recover all of the residual thromboembolic material.
Retraction cannot explain the volume reduction observed. The magnitude of the volume reduction alone makes this unlikely ( fig. 1 ). Furthermore, when thrombi were retained between ligatures for 3 hr in a peripheral vein (Group B), no retraction occurred, the volume of these retained thrombi being the same as that of control thrombi removed at zero time. Wessler also has reported no retraction of venous thrombi retained for up to 4 hr in vivo in the dog. 16 Finally, substantial declines occurred in both weight and volume of the thromboemboli, indicating no major change in clot density. The lack of retraction may be explained by the high cellularity of these serum-induced thrombi,20 their lack of contact with surfaces other than intact vascular intima, and by the fact that control observations were not made until some 30 min after thrombus induction.
Volume reduction due to organization plays no role in these acute studies, as verified by the microscopic results. Nor does technical failure to harvest the residual thromboemboli appear to make a major contribution. Results in Group 1 indicate that this failure may contribute a 10% average volume loss, but the meticulous dissection techniques used make it highly unlikely that additional embolic material went undiscovered at autopsy. It was possible to visualize and express embolic material from vessels as small as 1 mm, and pathologic sections from various areas of the embolized lungs failed to demonstrate emboli in vessels smaller than 1 mm. Thus, fibrinolytic dissolution presents the only acceptable explanation for the substantial reductions in volume which occurred both post mortem and in vivo. We now turn to the question of whether this fibrinolytic activity is blood borne, arises locally from the intima of the vessels subjected to thromboembolism, or is dependent upon interaction of both possibilities. Failure of jugular vein thrombi to dissolve post mortem or when excluded from the circulation suggests that local factors do not exert a major thrombolytic influence. And we have observed that IVC thrombi retained between ligatures for many hours do not undergo volume reduction. Yet dissolution of reperfused jugular venous thrombi did occur more slowly than dissolution of pulmonary emboli in vivo. This may reflect the fact that uniform flow rates through the thrombus-containing jugular segment were not accomplished by the technique used. However, not only were in vivo resolution rates of JV thrombi substantially below those in the pulmonary artery but post mortem JV thrombus dissolution also failed to occur, while that of the PA thromboemboli was appreciable. These in vivo and post mortem disparties suggest that there is some local contribution to fibrinolytic activity by vessel walls. Just-Viera et al.5 also have suggested that thromboembolic resolution proceeds more rapidly in the pulmonary arterial vasculature than in peripheral veins. The validity of this view and the mechanisms involved require further exploration.
Our data also disclosed significant variation in resolution rates from one dog to another, both in vivo and post mortem. For example, one Group III dog showed no embolic resolution at 3 hr; another, 91% reduction. This would suggest that the fibrinolytic mechanism is activated to a varying degree in different animals. Variations in human responsiveness to agents which release endogenous plasminogen activator are known to occur.2' Whether this same phenomenon is somehow operative in the response to thromboembolism in dogs or man must remain speculative. Behavior of the fibrinolytic system was not assessed in this study.
Finally, the morphologic changes observed in both in vivo emboli and reperfused JV thrombi demonstrate that, while dissolution leads to substantial reduction of the original clot volume, accretion of platelets and fibrin on the clot surface adds to this volume. Thus, the net volume change observed is conditioned by the time course and extent of these opposing events. The accelerated volume decrement in heparin-treated animals supports this view. The morphology of thrombi also indicates that heparin blocks the characteristic layering observed in thrombi from the nonheparinized dogs.
Pathophysiologic and Clinical Implications
The extent to which our data can be related to cardiopulmonary functional changes following thromboembolism in man is limited by two unknowns: 1) the extent to which volume/weight decrements in thromboemboli correlate with restoration of vascular lumen; and 2) the degree to which observations in the dog can be transposed in man. Despite such limitations, certain potential implications should be considered. For example, both the post mortem and in vivo embolic observations may bear upon the disparity often observed between the extent of embolism judged antemortem and the lesser extent observed at autopsy. Even if a patient dies suddenly with pulmonary embolism, there is usually a significant delay between death and autopsy. Few patients reach autopsy less than three hours after demise, and this is the period of substantial volume reduction, as demonstrated in this study. Furthermore, the majority of patients who die with pulmonary embolism do not succumb immediately. Therefore the amount of embolic material found at autopsy is subject to dissolution before as well as after death. Thus, a marked disparity may develop between the apparent extent of embolism at autopsy and the cardiopulmonary consequences observed by the clinician prior to death.
Another implication of our results relates to the postembolic cardiopulmonary behavior of patients. Rapid dissolution of an embolus can radically alter the cardiopulmonary status of a given patient. Furthermore, the extent of dissolution need not correlate with the extent of improvement. Modest dissolution can lead to substantial hemodynamic Circulation, Volume XLVIII, July 1973 improvement. Previous reports indicate the crosssectional area of a pulmonary arterial vessel must be narrowed by 60-70% before a significant increase in resistance leads to a major decrement in flow to the distal lung zone supplied by that vessel. [22] [23] [24] With respect to thromboembolism, this implies that 30 to 40% dissolution of a totally obstructing thrombus should be associated with restoration of blood flow, provided that percentage dissolution correlates with percentage luminal area restored. Pulmonary scintiphotography in animals and man repeatedly has disclosed that normal or modestly reduced blood flow reaches lung zones despite angiographic and/or autopsy evidence of substantial thrombotic occlusion.18 Furthermore, if partial dissolution leads to distal movement of an embolus lodged initially in a larger pulmonary artery, substantial hemodynamic improvement will occur.
Finally, the data indicate that the use of heparin may hasten the resolution of fresh thromboemboli by preventing accretion of fibrin-platelet layers on the thrombus surface, thus allowing fibrinolytic dissolution to proceed unopposed.
